Literature DB >> 7459176

Coronary and peripheral arterial responses to ergometrine in patients susceptible to coronary and oesophageal spasm.

J J Dalal, A M Dart, H A Davies, D J Sheridan, M S Ruttley, A H Henderson.   

Abstract

Vascular responses to ergometrine were compared in groups of patients subject to coronary artery spasm, or oesophageal spasm, or neither. We measured the degree of diffuse narrowing at different coronary artery sites (not in spasm), and the rise in blood pressure. The data provide no evidence for a generalised sensitivity to alpha-adrenergic stimulation underlying either of these two clinical entities. The left main stem was narrowed significantly less than the three main branches of the coronary artery tree. The degree of diffuse coronary artery narrowing was not influenced by the presence or absence of minor (less than or equal to 50%) fixed stenotic lesions, nor by the initial calibre of the arteries. Ergometrine did not alter arterial lactate concentration or lactate extraction in the absence of coronary spasm.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7459176      PMCID: PMC482507          DOI: 10.1136/hrt.45.2.181

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  19 in total

1.  Vasopressor activity of ergometrine.

Authors:  J S CRAWFORD
Journal:  Br Med J       Date:  1963-05-11

2.  Vasopressor activity of ergometrine maleate in anaesthetized parturient women.

Authors:  T W BAILLIE
Journal:  Br Med J       Date:  1963-03-02

3.  Letter: Ergotrate in coronary artery spasm.

Authors:  T O Cheng
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

4.  Serious side effects of ergometrine and its use in routine obstetric practice.

Authors:  D J Browning
Journal:  Med J Aust       Date:  1974-06-15       Impact factor: 7.738

5.  Myocardial infarction in the absence of coronary arteriosclerosis. Result of coronary spasm (?).

Authors:  T O Cheng; T Bashour; B K Singh; G A Kelser
Journal:  Am J Cardiol       Date:  1972-11-08       Impact factor: 2.778

6.  Coronary heart disease. Clinical, cinearteriographic and metabolic correlations.

Authors:  L S Cohen; W C Elliott; M D Klein; R Gorlin
Journal:  Am J Cardiol       Date:  1966-02       Impact factor: 2.778

7.  Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography.

Authors:  H Yasue; M Touyama; H Kato; S Tanaka; F Akiyama
Journal:  Am Heart J       Date:  1976-02       Impact factor: 4.749

8.  Oesophageal spasm and angina: diagnostic value of ergometrine (ergonovine) provocation.

Authors:  A M Dart; H A Davies; R H Lowndes; J Dalal; M Ruttley; A H Henderson
Journal:  Eur Heart J       Date:  1980-04       Impact factor: 29.983

9.  Coronary hemodynamic effects of ergonovine maleate in human subjects.

Authors:  A E Orlock; D R Ricci; P R Cipriano; D F Guthaner; D C Harrison
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

10.  The cardiovascular effects of ergometrine in the experimental animal in vivo and in vitro.

Authors:  M R Wassef; H Lal; B J Pleuvry
Journal:  Br J Anaesth       Date:  1974-07       Impact factor: 9.166

View more
  2 in total

1.  Graded esophageal balloon distention. A new provocative test for noncardiac chest pain.

Authors:  C F Barish; D O Castell; J E Richter
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

2.  Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin.

Authors:  G Ghillebert; J Janssens; G Vantrappen; F Nevens; J Piessens
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.